In vitro evaluations of konjac glucomannan and xanthan gum mixture as the sustained release material of matrix tablet

Carbohydrate Polymers

Volumn 73, Issue 2, 2008, Pages 241-247

  Fan, Jiangyang ^a   Wang, Kang ^a   Liu, Meimei ^a   He, Zhimin ^a  

^a UNILAB Research Center of Chemical Reaction Engineering   (China)

Author keywords

Konjac glucomannan; Sustained release matrix tablet; Synergistic interaction; Xanthan gum

Indexed keywords

BIOMIMETICS; DRUG DELIVERY; ENZYME ACTIVITY; HYDROLYSIS; POLYSACCHARIDES;

KONJAC GLUCOMANNAN; SUSTAINED RELEASE MATRIX TABLET; SYNERGISTIC INTERACTION; XANTHAN GUM;

DRUG PRODUCTS;

RATTUS;

EID: 41549101433     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2007.11.027     Document Type: Article

References (25)

1. Annable P., Williams P.A., and Nishinari K. Interaction in Xanthan-glucomannan mixtures and the influence of electrolyte. Macromolecules 27 (1994) 4204-4211
2. Burke M.D., Park J.O., Srinivasarao M., and Khan S.A. A novel enzymatic technique for limiting drug mobility in a hydrogel matrix. Journal of Controlled Release 104 (2005) 141-153
3. Burtin C., Noirot C., Scheinmann P., Galoppin L., Sabolovic D., and Bernard P. Clinical improvement in advanced cancer disease after treatment combining histamine and H2-anti-histanminics (ranitidine or cimetidine). European Journal of Cancer Clinical Oncology 24 (1988) 161-167
4. Chen L.G., Liu Z.L., and Zhuo R.X. Synthesis and properties of degradable hydrogels of konjac glucomannan grafted acrylic acid for colon-specific drug delivery. Polymer 46 (2005) 6274-6281
5. Dave V., Sheth M., McCarthy S.P., Ratto J.A., and Kaplan D.L. Liquid crystalline, rheological and thermal properties of konjac Glucomannan. Polymer 39 (1998) 1139-1148
6. Feng Y.Y., He Z.M., Ong S.L., Hu J.Y., Zhang Z.G., and Ng W.J. Optimization of agitation, aeration, and temperature conditions for maximum β-mannanase production. Enzyme and Microbial Technology 32 (2003) 282-289
7. Freston J.W. Cimetidine I. Development, pharamacology, and efficacy. Annals of Internal Medicine 97 (1982) 573-580
8. Gliko-Kabir I., Yagen B., Baluom M., and Rubinstein A. Phosphated crosslinked guar for colon-spicific drug delivery II. In vitro and in vivo evaluation in the rat. Journal of Controlled Release 63 (2000) 129-134
9. Goycoolea F.M., Richardson R.K., Morris E.R., and Gidley M.J. Stoichiometry and conformation of xanthan in synergistic gelation with locust bean gum or konjac glucomannan: Evidence for heterotypic binding. Macromolecules 28 (1995) 8308-8320
10. He Z.M., Zhang J., and Huang D. A kinetic correlation for konjac powder hydrolysis by β-mannanase from Bacillus licheniformis. Biotechnology Letters 23 (2001) 389-393
11. Huang C.Y., Zhang M.Y., and Peng S.S. Effect of konjac food on blood glucose level in patients with diabetes. Biomedical and Environmental Science 3 (1990) 123-131
12. Kang K.S., and Pettitt D.J. Xanthan, Gellan, Welan, & Rhansan. In: Whistler R.L., and Bemiller J.N. (Eds). Industrial gums. polysaccharides and their derivatives. 3rd ed. (1993), Academic Press, New York 341-371
13. Liu Z.L., Hu H., and Zhuo R.X. Konjac glucomannan-graft-acrylic acid hydrogels containing azo crosslinker for colon-specific delivery. Journal of Polymer Science Part A: Polymer Chemistry 42 (2004) 4370-4378
14. Nakano M., Takikawa K., and Arita T. Release characteristics of dibucaine dispersed in konjac gels. Journal of Biomedical Material Research Part A 13 (1979) 811-819
15. Paradossi G., Chiessi E., Barbiroli A., and Fessas D. Xanthan and glucomannan mixtures: Synergistic interactions and gelation. Biomacromolecules 3 (2002) 498-504
16. Sinha V.R., and Kumria R. Microbially triggered drug delivery to the colon. European Journal of Pharmaceutical Science 18 (2003) 3-18
17. Sinha V.R., Mittal B.R., Bhutani K.K., and Kumria R. Colonic drug delivery of 5-fluorouracil: An in vitro evaluation. International Journal of Pharmaceutics 269 (2004) 101-108
18. Sinha V.R., Mittal B.R., and Kumria R. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery. International Journal of Pharmaceutics 289 (2005) 79-85
19. Takeshi N., Masataka S., Ryozo N., and Masatoshi M. Cimetidine inhibits angiogenesis and suppresses tumor growth. Biomedical and Pharmacotherapy 59 (2005) 56-60
20. Talukdar M.M., and Kinget K. Swelling and drug release behavior of xanthan gum matrix tablets. Drug Development and Industrial Pharmacy 120 (1995) 63-72
21. Tonnesen H., Knigge U., Bulow S., Damm P., Fischerman K., and Hesselfeldt P. Effect of cimetidine on survival after gastric cancer. Lancet 2 (1988) 990-992
22. Vuksan V., Jenkins D.J., and Spadafora P. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A Randomized Controlled Metabolic Trial Diabetes Care 22 (1999) 913-919
23. Wang K., and He Z.M. Alginate-konjac glucomannan-chitosan beads as controlled release matrix. International Journal of Pharmaceutics 244 (2002) 117-126
24. Wong D., Larrabee S., Clifford K., Tremblay J., and Friend D.R. USP dissolution apparatus III (reciprocating cylinder) for screening of guar-based colonic delivery formulation. Journal of Controlled Release 47 (1997) 173-179
25. Zhang Y.Q., Xie B.J., and Gan X. Advance in the applications of konjac glucomannan and its derivatives. Carbohydrate Polymers 60 (2005) 27-31